Genelux Corporation ( GNLX) - Stock Earnings
GNLX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
GNLX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | -9.2 million USD | 8000 USD |
| 2026Q1 | -7.1 million USD | — USD |
| 2026Q2 | -9.5 million USD | — USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
GNLX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -28.3 million USD | 170000 USD |
| 2024 | -29.9 million USD | 8000 USD |
| 2025 | -32.1 million USD | 8000 USD |
| 2026 Est. | — | — |
GNLX
Price: $2.42
52 week price:
Earnings Per Share: -0.86 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 113.9 million